# Neurocrine Biosciences Inc. (NBIX) — Gross Profit

## Annual Gross Profit (USD)

| Year | Gross Profit |
| --- | --- |
| 2025 | $2.81B |
| 2024 | $2.32B |
| 2023 | $1.85B |
| 2022 | $1.47B |
| 2021 | $1.12B |
| 2020 | $1.04B |
| 2018 | $446M |
| 2017 | $160M |
| 2016 | $15M |
| 2015 | $20M |

## Quarterly Gross Profit (USD)

| Quarter | Gross Profit |
| --- | --- |
| 2026-03-31 | $801M |
| 2025-09-30 | $781M |
| 2025-06-30 | $676M |
| 2025-03-31 | $563M |
| 2024-09-30 | $614M |
| 2024-06-30 | $581M |
| 2024-03-31 | $508M |
| 2023-09-30 | $488M |
| 2023-06-30 | $441M |
| 2023-03-31 | $412M |
| 2022-09-30 | $382M |
| 2022-06-30 | $373M |
| 2022-03-31 | $306M |
| 2021-09-30 | $292M |
| 2021-06-30 | $286M |
| 2021-03-31 | $234M |
| 2020-09-30 | $256M |
| 2020-06-30 | $300M |
| 2020-03-31 | $235M |
| 2019-09-30 | $220M |
| 2019-06-30 | $182M |
| 2019-03-31 | $137M |
| 2018-09-30 | $150M |
| 2018-06-30 | $96M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/NBIX/gross-profit)